Currently, there are several generics on the U.S. market of oral antifungal agent ketoconazole. But consumer advocacy organization Public Citizen is trying to change that. On Tuesday, it petitioned the FDA to pull them from the market, claiming the med's risks of fatal liver failure and adrenal insufficiency--as well as its "numerous drug interactions"--outweigh benefits it deemed "limited." Petition (PDF)